1 The Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. l.akkari@nki.nl.
2 Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA. sfinley@usc.edu.
3 Department of Oncology, University of Lausanne, Lausanne, Switzerland. ping-chih.ho@unil.ch.
4 Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. ping-chih.ho@unil.ch.
5 The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Victoria, Australia. jenkins.m@wehi.edu.au.
6 Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna, Austria. bmaier@cemm.oeaw.ac.at.
7 CRUK-UCL Lung Cancer Centre of Excellence, University College London, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
8 Aga Khan University, Nairobi, Kenya. miriam.mutebi@aku.edu.
9 VP East Africa, African Organization for Research and training in Cancer (AORTIC), Nairobi, Kenya. miriam.mutebi@aku.edu.
10 Department of Anatomy, Department of Pathology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Rushika.Perera@ucsf.edu.
11 International Laboratory for Human Genome Research, National Autonomous University of Mexico, Queretaro, Mexico. drobles@liigh.unam.mx.
12 Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton Cambridge, UK. drobles@liigh.unam.mx.
13 Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.
14 University of Pennsylvania, Philadelphia, PA, USA. Liling.Wan@Pennmedicine.upenn.edu.